Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-23

Clinical Trial Update: Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and efficacy of sublingual grass pollen allergen extract tablets for seasonal allergic rhinitis; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Grass Pollen Allergen Extract Sublingual Tablet (grass pollen allergen extract)

Snippet

Sponsor: Stallergenes Greer | Conditions: Seasonal Allergic Rhinitis | Phase 1 | Status: COMPLETED | Results posted: 2016-05-23